Matches in Wikidata for { <http://www.wikidata.org/entity/Q95381227> ?p ?o ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- Q95381227 description "article scientifique publié en 2014" @default.
- Q95381227 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95381227 description "wetenschappelijk artikel" @default.
- Q95381227 description "наукова стаття, опублікована в лютому 2014" @default.
- Q95381227 name "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 name "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 type Item @default.
- Q95381227 label "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 label "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 prefLabel "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 prefLabel "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 P1433 Q95381227-6241705D-B364-4393-A449-14A0D043AA35 @default.
- Q95381227 P1476 Q95381227-33CE1AB7-2B7F-435E-87F2-18A81CC6DE86 @default.
- Q95381227 P304 Q95381227-5D65B279-7274-45FD-990C-9319C565C897 @default.
- Q95381227 P31 Q95381227-B75496EF-F645-41A8-9DF8-B32F134787FF @default.
- Q95381227 P433 Q95381227-10F3DFE8-4F2C-449A-8B64-028742875F71 @default.
- Q95381227 P478 Q95381227-18947DDA-7FBF-4CA8-938D-FBE8E287000C @default.
- Q95381227 P577 Q95381227-A730B229-3D63-418B-BA69-00D343AE7B4D @default.
- Q95381227 P698 Q95381227-1542F509-A534-4B3E-9422-41B66924F718 @default.
- Q95381227 P698 24852792 @default.
- Q95381227 P1433 Q26867024 @default.
- Q95381227 P1476 "Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma" @default.
- Q95381227 P304 "14-16" @default.
- Q95381227 P31 Q13442814 @default.
- Q95381227 P433 "2 Suppl 5" @default.
- Q95381227 P478 "12" @default.
- Q95381227 P577 "2014-02-01T00:00:00Z" @default.
- Q95381227 P698 "24852792" @default.